Trastuzumab-resistant breast cancer cells-derived tumor xenograft models exhibit distinct sensitivity to lapatinib treatment in vivo

被引：0
|
作者：
Hao Liu
Sanbao Ruan
Margaret E. Larsen
Congcong Tan
Bolin Liu
Hui Lyu
机构：
[1] Louisiana State University (LSU) Health Sciences Center,Departments of Interdisciplinary Oncology and Genetics, Stanley S. Scott Cancer Center, School of Medicine
[2] Affiliated Cancer Hospital & Institute of Guangzhou Medical University,undefined
来源：
Biological Procedures Online | / 25卷
关键词：
Therapeutic resistance; HER2-targeted therapy; In vivo tumor models; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Combined targeting of HER2 and HER3 inhibits tumor growth in both trastuzumab-sensitive and trastuzumab-resistant breast cancer models.
    Steiner, Philipp
    Wetzel, Leslie
    Schifferli, Kevin
    Rothstein, Raymond
    Tammali, Ravinder
    Rebelatto, Marlon
    Xiao, Zhan
    Pierce, Andrew
    Hollingsworth, Robert
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [32] Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models
    Buocikova, Verona
    Longhin, Eleonora Marta
    Pilalis, Eleftherios
    Mastrokalou, Chara
    Miklikova, Svetlana
    Cihova, Marina
    Poturnayova, Alexandra
    Mackova, Katarina
    Babelova, Andrea
    Trnkova, Lenka
    El Yamani, Naouale
    Zheng, Congying
    Rios-Mondragon, Ivan
    Labudova, Martina
    Csaderova, Lucia
    Kuracinova, Kristina Mikus
    Makovicky, Peter
    Kucerova, Lucia
    Matuskova, Miroslava
    Cimpan, Mihaela Roxana
    Dusinska, Maria
    Babal, Pavel
    Chatziioannou, Aristotelis
    Gabelova, Alena
    Runden-Pran, Elise
    Smolkova, Bozena
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 147
  • [33] The dual EGFR/HER-2 kinase inhibitor lapatinib induces apoptosis and potentiates anti-IGF-IR therapy in trastuzumab-resistant breast cancer cells
    Nahta, Rita
    Yuan, Linda Xh
    Esteva, Francisco J.
    CANCER RESEARCH, 2006, 66 (08)
  • [34] Trastuzumab derived HER2-specific CAR for trastuzumab-resistant breast cancer: CAR T-cells successfully engage target epitopes that are not accessible to antibodies
    Szoor, A.
    Toth, G.
    Zsebik, B.
    Szabo, V.
    Eshhar, Z.
    Abken, H.
    Vereb, G.
    HUMAN GENE THERAPY, 2019, 30 (11) : A7 - A7
  • [35] The erbB3 blocking antibody MM-121 resensitizes trastuzumab-resistant breast cancer cells to trastuzumab-mediated antitumor activity in vitro and in vivo
    Huang, Jingcao
    Lyu, Hui
    Lee, Youngseok
    Liu, Bolin
    MOLECULAR CANCER RESEARCH, 2013, 11
  • [36] Lapatinib induces apoptosis in trastuzumab-resistant breast cancer cells: effects on insulin-like growth factor I signaling (vol 6, pg 667, 2007)
    Nahta, R.
    Yuan, L. X.
    Du, Y.
    Esteva, F. J.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (11) : 3654 - 3654
  • [37] Trastuzumab-resistant HER2-positive metastatic breast cancer: Comparing results of lapatinib and capecitabine in brain and other metastatic sites.
    Cortes, E. J.
    Bomfim, M.
    Freitas, B. V.
    Muller, F.
    Silva, E. R.
    da Silva, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [38] Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells
    Gao, Yu
    Shelling, Andrew N.
    Nolan, Emma
    Porter, David
    Leung, Euphemia
    Wu, Zimei
    JOURNAL OF LIPOSOME RESEARCH, 2024, 34 (03) : 489 - 506
  • [39] Nuclear Function of ErbB-2/ErbB-3 Heterodimers in Trastuzumab-Resistant Breast Cancer Cells
    Cordo Russo, Rosalia Inas
    Beguelin, Wendy
    Diaz Flaque, Maria Celeste
    Chiauzzi, Violeta A.
    Venturutti, Leandro
    Galigniana, Natalia M.
    Proietti, Cecilia J.
    Charreau, Eduardo H.
    Schillaci, Roxana
    Virginia Elizalde, Patricia
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [40] A novel humanized MUC1 antibody-drug conjugate for the treatment of trastuzumab-resistant breast cancer
    Wu, Guang
    Li, Lan
    Qiu, Yuxin
    Sun, Wei
    Ren, Tianhao
    Lv, Yingshuai
    Liu, Mengnan
    Wang, Xiaoxia
    Tao, Hongqun
    Zhao, Lingjie
    Cao, Jiawei
    He, Licai
    Li, Hongzhi
    Gu, Haihua
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2021, 53 (12) : 1625 - 1639
12345